Showing 951-960 of 1319 results for "".
Oral Disease Modifying Therapy for MS: Important Considerations
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/oral-disease-modifying-therapy-for-ms-important-considerations/30827/The availability of an oral agent for MS may create a therapeutic dilemma for clinicians as they try to determine the role of new therapy in patient care.- Add Zest to Your Patients' Palateshttps://practicalneurology.com/columns/practice-management/add-zest-to-your-patients-palates/31057/Smell and Taste Impairments in Neurological Practice: Diagnostic and Management StrategiesSmell (olfactory) and taste (gustatory) impairments affect approximately 15 million adults in the United States, predominantly those aged 55 and older. These sensory deficits are frequently associated with neur
- Editorial Board & Contributorshttps://practicalneurology.com/columns/practice-management/editorial-board-contributors/31072/January 2008 Issue of Practical Neurology Highlights Esteemed Editorial and Contributor TeamThe January 2008 issue of *Practical Neurology* underscores its commitment to delivering high-quality neurological insights through a distinguished editorial and contributor team. Dr. Stephen Gollomp, Chief o
- Will Generics Gobble Up The Neurology Market?https://practicalneurology.com/columns/practice-management/will-generics-gobble-up-the-neurology-market/31082/Generics Gain Ground in Neurology: Implications for Clinical PracticeThe landscape of neurology pharmacotherapy is shifting as generic medications increasingly replace brand-name drugs, promising substantial cost savings without compromising efficacy. As highlighted in the December 2007 issue of *Pr
- Pain Managementhttps://practicalneurology.com/diseases-diagnoses/headache-pain/PN1206painmngmt-pdf/31240/Identifying Pharmacologic Triggers in Migraine Management: Insights from Clinical CasesMigraine management poses significant challenges, particularly when pharmacologic interventions inadvertently exacerbate headache disorders. Dr. Charles Argoff’s article in *Practical Neurology* explores this issu
- After the Stroke: A Walk Through the Rehab Processhttps://practicalneurology.com/diseases-diagnoses/stroke/pn0706feaStroke-pdf/31297/Comprehensive Insights into Stroke Rehabilitation for NeurologistsIn the acute phase of a stroke, neurologists play a pivotal role, guiding the etiological investigation, selecting appropriate treatments, and counseling families on prognosis and follow-up care. Post-acute discharge decisions, whethe
- Business Advisorhttps://practicalneurology.com/columns/practice-management/business-advisor/31360/In the rapidly evolving healthcare landscape, prioritizing patient-centered care remains crucial, particularly in neurology practices. Increasing pressures from payers have compelled providers to see more patients in less time, often shifting the focus from individual patient needs to systemic effic
Acute-Onset Weakness, Deafness, and Confusion: A Case of Multisystem Thiamine Deficiency
https://practicalneurology.com/diseases-diagnoses/neuromuscular/acute-onset-weakness-deafness-and-confusion-a-case-of-multisystem-thiamine-deficiency/32006/Vigilance for less-common manifestations of thiamine deficiency may help with diagnosis.Stigma of Alzheimer's Disease Dementia
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/stigma-of-alzheimers-disease-dementia/30229/Clinicians can address the challenges of stigma in routine clinical practice.Parry-Romberg Syndrome With Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/child-neurology/parry-romberg-syndrome-with-drug-resistant-epilepsy/31841/En coup de epilepsie—seizures, headaches, and imaging findings ipsilateral to cutaneous manifestations.